About The Cover
The cover for issue 21 of Oncotarget features Figure 6, "MGMTlow/MMRproficient/LOHhigh PDX models are responsive to the TMZ + ATRi combination," by El Touny, et al. .
Table of Contents
Priority Research Papers
ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomide
| ATR inhibition reverses the resistance of homologous recombination deficient MGMTlow/MMRproficient cancer cells to temozolomide |
|
https://doi.org/10.18632/oncotarget.28090 Lara H. El Touny, Curtis Hose, John Connelly, Erik Harris, Anne Monks, Angie B. Dull, Deborah F. Wilsker, Melinda G. Hollingshead, Michelle Gottholm-Ahalt, Sergio Y. Alcoser, Michael E. Mullendore, Ralph E. Parchment, James H. Doroshow, Beverly A. Teicher, and Annamaria Rapisarda |
| 2114-2130 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release |
Research Papers
Hyperprogression of a mismatch repair-deficient colon cancer in a humanized mouse model following administration of immune checkpoint inhibitor pembrolizumab
| Hyperprogression of a mismatch repair-deficient colon cancer in a humanized mouse model following administration of immune checkpoint inhibitor pembrolizumab |
|
https://doi.org/10.18632/oncotarget.28086 Ilyas Sahin, Andrew George, Shengliang Zhang, Kelsey E. Huntington, Zehra Ordulu, Lanlan Zhou, and Wafik S. El-Deiry |
| 2131-2146 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release |
Luminescence complementation technology for the identification of MYC:TRRAP inhibitors
| Luminescence complementation technology for the identification of MYC:TRRAP inhibitors |
|
https://doi.org/10.18632/oncotarget.28078 Edmond J. Feris, John W. Hinds, and Michael D. Cole |
| 2147-2157 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release |
TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan
| TAK1-inhibitors are cytotoxic for multiple myeloma cells alone and in combination with melphalan |
|
https://doi.org/10.18632/oncotarget.28073 Erling Håland, Ingrid Nyhus Moen, Elias Veidal, Hanne Hella, Kristine Misund, Tobias S. Slørdahl, and Kristian K. Starheim |
| 2158-2168 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release |
The experiences and needs of Australian medical oncologists in integrating comprehensive genomic profiling into clinical care: a nation-wide survey
| The experiences and needs of Australian medical oncologists in integrating comprehensive genomic profiling into clinical care: a nation-wide survey |
|
https://doi.org/10.18632/oncotarget.28076 Subotheni Thavaneswaran, Mandy Ballinger, Phyllis Butow, Bettina Meiser, David Goldstein, Frank Lin, Christine Napier, David Thomas, and Megan Best |
| 2169-2176 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release |
Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma
| Low tumour-infiltrating lymphocyte density in primary and recurrent glioblastoma |
|
https://doi.org/10.18632/oncotarget.28069 Kelsey Maddison, Moira C. Graves, Nikola A. Bowden, Michael Fay, Ricardo E. Vilain, Sam Faulkner, and Paul A. Tooney |
| 2177-2187 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release |
Trends in oligomannosylation and α1,2-mannosidase expression in human cancers
| Trends in oligomannosylation and α1,2-mannosidase expression in human cancers |
|
https://doi.org/10.18632/oncotarget.28064 Sayantani Chatterjee, Julian Ugonotti, Ling Y. Lee, Arun Everest-Dass, Rebeca Kawahara, and Morten Thaysen-Andersen |
| 2188-2205 |
| Abstract | PDF | Full Text | Supplementary Information | How to cite | Press Release |
TP53 mutations determined by targeted NGS in breast cancer: a case-control study
| TP53 mutations determined by targeted NGS in breast cancer: a case-control study |
|
https://doi.org/10.18632/oncotarget.28071 Angeliki Andrikopoulou, Evangelos Terpos, Spyridoula Chatzinikolaou, Kleoniki Apostolidou, Ioannis Ntanasis-Stathopoulos, Maria Gavriatopoulou, Meletios-Athanasios Dimopoulos, and Flora Zagouri |
| 2206-2214 |
| Abstract | PDF | Full Text | How to cite | Press Release |
|
Association of four genetic variants with colorectal cancer in Kazakhstan population
| Association of four genetic variants with colorectal cancer in Kazakhstan population |
|
https://doi.org/10.18632/oncotarget.28070 Yevgeniya Kolesnikova, Dmitriy Babenko, Irina Kadyrova, Svetlana Kolesnichenko, Lyudmila Akhmaltdinova, Ilya Korshukov, Naylya Kabildina, Valentina Sirota, Vera Zhumaliyeva, Dana Taizhanova, Dmitriy Vazenmiller, and Anar Turmukhambetova |
| 2215-2222 |
| Abstract | PDF | Full Text | How to cite | Press Release |
Editorial
Javelin Head Neck 100: Should we combine immunotherapy with radiation therapy?
| Javelin Head Neck 100: Should we combine immunotherapy with radiation therapy? |
|
https://doi.org/10.18632/oncotarget.27987 Yao Yu, Kaveh Zakeri, and Nancy Lee |
| 2223-2226 |
| PDF | How to cite |
Research Perspectives
Neddylation and anti-tumor immunity
| Neddylation and anti-tumor immunity |
|
https://doi.org/10.18632/oncotarget.28019 Xiaoguang Wang, Scott Best, and Alexey V. Danilov |
| 2227-2230 |
| Abstract | PDF | Full Text | How to cite |
Corrections
Correction: Discovery and clinical introduction of first-in-class imipridone ONC201
| Correction: Discovery and clinical introduction of first-in-class imipridone ONC201 |
|
https://doi.org/10.18632/oncotarget.28012 Joshua E. Allen, C. Leah B. Kline, Varun V. Prabhu, Jessica Wagner, Jo Ishizawa, Neel Madhukar, Avital Lev, Marie Baumeister, Lanlan Zhou, Amriti Lulla, Martin Stogniew, Lee Schalop, Cyril Benes, Howard L. Kaufman, Richard S. Pottorf, B. Rao Nallaganchu, Gary L. Olson, Fahd Al-Mulla, Madeleine Duvic, Gen Sheng Wu, David T. Dicker, Mala K. Talekar, Bora Lim, Olivier Elemento, Wolfgang Oster, Joseph Bertino, Keith Flaherty, Michael L. Wang, Gautam Borthakur, Michael Andreeff, Mark Stein, and Wafik S. El-Deiry |
| 2231-2231 |
| Correction | PDF | How to cite |
Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer
| Correction: Lipolysis-stimulated lipoprotein receptor overexpression is a novel predictor of poor clinical prognosis and a potential therapeutic target in gastric cancer |
|
https://doi.org/10.18632/oncotarget.28096 Takahito Sugase, Tsuyoshi Takahashi, Satoshi Serada, Minoru Fujimoto, Tomoharu Ohkawara, Kosuke Hiramatsu, Masahiro Koh, Yurina Saito, Koji Tanaka, Yasuhiro Miyazaki, Tomoki Makino, Yukinori Kurokawa, Makoto Yamasaki, Kiyokazu Nakajima, Kazuhiro Hanazaki, Masaki Mori, Yuichiro Doki, and Tetsuji Naka |
| 2232-2233 |
| Correction | PDF | How to cite |
Copyright © 2025 Rapamycin Press LLC dba Impact Journals
Oncotarget ® is a registered trademark of Rapamycin Press LLC
Impact Journals ® is a registered trademark of Rapamycin Press LLC